Closed-loop marketing (CLM) is a system of developing and revising communications based on direct and indirect consumer feedback. It's also a set of technological tools (databases, smartphone and tablet apps, websites) that enable rapid collection and analysis of data, and rapid revision and dissemination of communications. In short, it's on-demand communications customised for the customer.
Here's a brief analogy. Think about the experience of shopping for food produce, and how it's changed:
The supermarket uses CLM to achieve this – database-driven tools to customise offerings and communications to target demographics, with the ability to shift and realign messages in response to demonstrated customer behaviours and preferences. This same transformation is taking place in pharma.
How can pharma learn from the supermarket?
Adoption of CLM in pharma means that pharma reps and marketers can finally work in tandem with standard database marketing techniques that have been in place for years. It's the convergence of the best of the old (from the example above, our greengrocer's customer knowledge and personability) and the new (our supermarket's global reach and efficiency).
Through several vendors (Veeva, Skura, Agnitio, among others) – database marketing is now available at the sales rep level. Usually armed with an iPad or other tablet, a sales rep can pull up a screen in advance of a discussion with a physician, select that physician's profile, and automatically customise a presentation to that physician's needs and interests.
The iPad will show the previous calls with that physician, areas of interest (based on selections from previous details), suggested conversation topics, and suggested interactive engagements.
CLM can also incorporate 'self-driven' channels – for example, when a physician or pharmacist visits a product website, or logs in to a dedicated information-sharing portal. This information feeds into the professional's profile and preferences, adding greater richness to the rep/physician dialogue.
To some degree, CLM isn't really a new principle in pharma marketing so much as it is an acceleration and optimisation of established best practices through technology. With CLM, the basic principles of effective marketing are alive and not just well, but thriving. Now we not only identify and communicate a clear value proposition for a product, based on the specific unmet needs in the market we can do it based on the specific unmet needs of Dr Jones.
No results were found